Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype
- M. Shahmanesh*
- , H. Jaleel
- , Y. DeSilva
- , J. D.C. Ross
- , M. Caslake
- , R. Cramb
*Corresponding author for this work
- University Hospitals Birmingham NHS Foundation Trust
- Department of Pathological Biochemistry
- Department of Clinical Biochemistry
Research output: Contribution to journal › Article › peer-review
6
Citations
(SciVal)